Search Results
Jan 21, 2026, 07:00 ET L-Nutra Secures $36.5M Investment from Mubadala, Raising Series D Proceeds to $83.5M and Accelerating Global Expansion of Its Longevity and Medical Nutrition Therapies
decades advancing nutrition R&D and developing effective interventions that can be integrated within our healthcare system," said Joseph Antoun, MD, PhD, Chairman and CEO of L-Nutra. "By reformulating food into clinically validated nutrition programs, we now can support patients and individuals seeking
More news about: L-Nutra Inc.
Jan 21, 2026, 07:00 ET The T1D Fund Strengthens Expertise With Appointment of Biotech Industry Veteran and Cell Therapy Expert Teresa Foy, Ph.D., to Advance Next Generation of Type 1 Diabetes ("T1D") Therapies
multimedia:https://www.prnewswire.com/news-releases/the-t1d-fund-strengthens-expertise-with-appointment-of-biotech-industry-veteran-and-cell-therapy-expert-teresa-foy-phd-to-advance-next-generation-of-type-1-diabetes-t1d-therapies-302665772.htmlSOURCE
More news about: The T1D Fund
Jan 20, 2026, 19:24 ET ChooChoo, an AI Interactive Reading Toy Built on RiseLink Edge Intelligence, Featured at CES 2026 and Highlighted Across National and Local Media
improve children's language abilities in as little as one month when used consistently.ChooChoo was created by Dr. Diana Zhu (Yale PhD), combining academic research with warm, playful product design for children ages 3–6. Through natural conversation and adaptive storytelling,
More news about: Riselink
Jan 20, 2026, 19:15 ET Insilico Medicine and Hygtia Therapeutics Enter New Global Strategic Collaboration to Co-Develop Novel Brain Penetrant NLRP3 Inhibitor for CNS Diseases treatment
neuroinflammation via NLRP3 represents a scientifically sound and high-potential approach to treating neurodegenerative and age-related diseases," said Ren Feng, PhD, co-CEO and Chief Scientific Officer of Insilico Medicine. "However, developing a safe molecule with good blood-brain barrier penetration remains
More news about: Insilico Medicine
Jan 20, 2026, 12:37 ET Rosalind Franklin University Researcher Awarded $1.9M NIH Grant for Neurological Disease Research
Hongkyun Kim, PhD, professor of cell biology and anatomy in RFU's Center for Cancer Cell Biology, Immunology and Infection, was awarded a 5-year NIH grant from the National
More news about: Rosalind Franklin University of Medicine and Science
Jan 20, 2026, 11:00 ET American Academy of Pediatric Dentistry Announces Dr. Jessica Y. Lee as Next Chief Executive Officer
20, 2026 /PRNewswire/ -- The American Academy of Pediatric Dentistry (AAPD) proudly announces the appointment of Jessica Y. Lee, DDS, MPH, PhD, as its next Chief Executive Officer, transitioning June 1, 2026. A globally recognized leader in pediatric dentistry, health policy, and academic
More news about: American Academy of Pediatric Dentistry
Jan 20, 2026, 10:07 ET Katalyze AI Launches Katalyst: AI Agent for Pharmaceutical Manufacturing
introducing an AI agent grounded in the scientific principles manufacturing teams rely on to ensure consistency and quality," said Hannes Bretschneider, PhD, Chief AI Officer at Katalyze AI. "Its outputs are source-grounded, traceable, and reproducible - characteristics essential for any system operating
More news about: Katalyze AI
Jan 20, 2026, 09:00 ET Wisconsin allocates $10 million to Nurse Educator Program
dollars fund nurses pursuing a Master of Science in Nursing (MSN)-Nurse Educator, Doctor of Nursing Practice (DNP), Doctor of Nursing Education (DNE) or PhD degree, as well as post-doctoral fellowships, according to Linda K. Young, Co-Chair of the WNEP Advisory Council. Recipients are required to teach for
More news about: Wisconsin Nurse Educator Program
Jan 20, 2026, 08:18 ET PainTEQ Fuels Next Phase of Growth at NANS 2026 with Strategic Expansion of Innovation, Clinical Initiatives, and Product Portfolio
Evidence RevolutionPresenters: Shanth Thiyagalingam; Tim Deer, MD; Dawood Sayed, MD; Jordan Tate, MD, MPH; Leonardo Kapural, MD, PhDDate: Friday, January 23, 2026Time: 9:00 PM – 10:00 PM Venue: Toca Madera Las VegasAbout
More news about: PainTEQ
Jan 20, 2026, 08:05 ET New Expert Consensus Published in The Laryngoscope Recommends PAPZIMEOS (zopapogene imadenovec) as the New Standard of Care First-Line Treatment for Adults with Recurrent Respiratory Papillomatosis
importance of providing patients and physicians with clear, evidence-based guidance following the FDA approval of PAPZIMEOS," said Helen Sabzevari, PhD, President and CEO of Precigen."For physicians, this publication provides critical clarity by establishing a treatment algorithm for RRP
More news about: Precigen, Inc.
Jan 20, 2026, 08:04 ET Groundbreaking Remote Clinical Trial Shows GABA-Producing Probiotic Improves Sleep and Reduces Stress
quickly realized that when we were dealing with People Science, they were invested in the science that we were doing,"— Dr. Noah Zimmerman, PhD Chief Scientific Officer, Verb BioticsKey Study HighlightsDesign: Randomized, double-blind, placebo-controlled,
More news about: People Science, Inc.
Jan 20, 2026, 08:00 ET Professor Sarfaraz Niazi's Scientific Framework Adopted as FDA Modernizes Clinical Trial Evaluation Through Bayesian Methods
formally recognizing Bayesian approaches that align with the long-standing scientific framework developed and advanced by Professor Sarfaraz K. Niazi, PhD, for evaluating drug and biosimilar efficacy without redundant clinical studies.
More news about: Professor Sarfaraz K. Niazi
Jan 20, 2026, 07:00 ET Nanoscope Secures Japan MHLW Sakigake and Orphan Drug Designations Across Inherited Retinal Diseases - A First for a Retinal Gene Therapy
Samarendra Mohanty, PhD, President, and Chief Scientific Officer of Nanoscope Therapeutics. "Sakigake recognition underscores the novelty of MCO-010 as a one-time,
More news about: Nanoscope Therapeutics
Jan 20, 2026, 07:00 ET Clinical Trial Demonstrates Accurate Non-Invasive Detection of In Vivo Biologic Activity in Melanomas by the Orlucent® Skin Fluorescent Imaging System
additional trials to support regulatory approval."Our goal is to make advanced molecular insight simple and accessible," said Catherine Shachaf, PhD, Orlucent's Co-founder and Chief Scientific Officer. "SFI helps dermatologists move beyond surface features and understand what's happening inside a
More news about: Orlucent, Inc.
Jan 20, 2026, 07:00 ET Kootenay Commissions a Preliminary Economic Assessment on La Cigarra Silver Deposit and Continues to Aggressively Drill Columba
release. Qualified Persons The Mineral Resource Estimate was estimated by Allan Armitage, PhD., P.Geo. of SGS Geological Services, and is an independent Qualified Person as defined by NI 43-101. Dr. Armitage conducted a site visit to La Cigarra
More news about: Kootenay Silver Inc.
Jan 20, 2026, 01:51 ET EQT Life Sciences co-leads EUR 51 million Series B in Exciva to advance its Alzheimer's therapy into clinical Phase 2
Phase 2 trials are positive, it would be a significant milestone in symptomatic treatment options for patients with AD."Philip Scheltens, MD, PhD, Partner at EQT Life Sciences, said: "This investment illustrates the potential of Exciva to bring exciting innovation to a therapeutic area where Alzheimer's
More news about: EQT
Jan 20, 2026, 01:48 ET EQT Life Sciences co-leads EUR 51 million Series B in Exciva to advance its Alzheimer's therapy into clinical Phase 2
Phase 2 trials are positive, it would be a significant milestone in symptomatic treatment options for patients with AD."Philip Scheltens, MD, PhD, Partner at EQT Life Sciences, said: "This investment illustrates the potential of Exciva to bring exciting innovation to a therapeutic area where Alzheimer's
More news about: EQT
Jan 19, 2026, 22:30 ET SeedlingLabs Welcomes Dr. Sudhir Kumar Patnaik to its Advisory Board
engineering excellence and AI-driven systems, Dr. Sudhir has published and presented at reputed industry and academic journals and conferences, holds a PhD in Computer Science with a specialization in Artificial Intelligence, and has served on academic advisory boards at leading engineering institutions
More news about: SeedlingLabs Private Limited
Jan 19, 2026, 09:00 ET CRNA Week Celebrates 'Heart of Anesthesia'
recognize the skill, compassion, and leadership that nurse anesthetists bring to patient care every day across the commonwealth," said Jodie B. Szlachta, PhD, CRNA, president of the Pennsylvania Association of Nurse Anesthetists."Pennsylvania's CRNAs are essential to safe anesthesia care in hospitals,
More news about: Pennsylvania Association of Nurse Anesthetists
Jan 19, 2026, 08:32 ET Italy on the Move Brings 200+ Italy-US Biotech, Pharma and Investment Leaders Together in San Francisco During JPM Week
Eli Lilly).The program also featured a pitch session with Luca Emili (Chairman, InSilicoTrials Technologies), Massimiliano Clamer, PhD (Chairman, Immagina Biotechnology), Enzo Troncone (CEO and founder, Butterfly Decisions) and Leandro Agrò (Relationship Manager, It's
More news about: Italian Trade Agency
Jan 19, 2026, 00:43 ET AVIATION PIONEER ADITYA GHOSH, LIVER TRANSPLANT SPECIALIST DR. SUBHASH GUPTA RECEIVE HONORARY DOCTORATES AT AMITY UNIVERSITY HARYANA'S 12TH CONVOCATION
University celebrates 1,644 graduates, including 1,555 graduands and 89 PhD scholars, at Bharat Mandapam ceremonyNEW DELHI, Jan. 19, 2026 /PRNewswire/ -- Aditya Ghosh, Co-Founder of Akasa Air and
More news about: Amity University Haryana
Jan 16, 2026, 12:07 ET Crosswalk Therapeutics Secures National MPS Society Grant to Address Unmet Skeletal Disease in Morquio A Syndrome
approaches."Morquio A syndrome is a devastating condition with significant unmet need, particularly in skeletal disease," said Madhu Natarajan, PhD, Chief Executive Officer of Crosswalk Therapeutics. "This grant enables our team to pursue a fundamentally different approach to enzyme therapy, focused
More news about: Crosswalk Therapeutics, Inc
Jan 16, 2026, 11:00 ET Equinox Integrates Oura Ring Data Into EQX ARC, New Women's Health & Performance Program
integration reflects a shared commitment to advancing women's health through data-informed, personalized training programs," said Dr. Chris Curry, MD, PhD, Clinical Director of Women's Health at ŌURA. "Oura's insights help women understand how their bodies respond to training, stress, last nights' sleep,
More news about: Equinox Group
Jan 16, 2026, 10:52 ET ELLEVET SCIENCES LAUNCHES FELINE CHEWS WITH CBD + CBDA
their owners."Having a palatable option is critical for consistent use, which ultimately drives better outcomes," said Joseph Wakshlag, DVM, PhD, DACVIM (Nutrition), DACVSMR and Chief Veterinary Medical Officer at ElleVet Sciences. "Early data and owner feedback show meaningful results in
More news about: ElleVet Sciences
Jan 16, 2026, 10:00 ET From Awareness to Action: Linus Health Drives the Next Era of Early Brain Health Detection
and partners across the healthcare industry."Brain health is one of the most urgent issues in healthcare and life sciences," said David Bates, PhD, CEO and co-founder of Linus Health. "Across the industry, there is growing recognition that waiting for symptoms to become obvious is no longer acceptable.
More news about: Linus Health